Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial
Saito Y, Okada S, Ogawa H, et al. Circulation. Pub. online November 15, 2016 http://circ.ahajournals.org/content/early/2016/11/09/CIRCULATIONAHA.116.025760.abstract
Leggi